227 related articles for article (PubMed ID: 1547888)
41. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
42. Sequence determination of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy.
Kettenring JK; Malabarba A; Vékey K; Cavalleri B
J Antibiot (Tokyo); 1990 Sep; 43(9):1082-8. PubMed ID: 2211371
[TBL] [Abstract][Full Text] [Related]
43. Structure of the Bacillus subtilis peptide antibiotic subtilosin A determined by 1H-NMR and matrix assisted laser desorption/ionization time-of-flight mass spectrometry.
Marx R; Stein T; Entian KD; Glaser SJ
J Protein Chem; 2001 Aug; 20(6):501-6. PubMed ID: 11760125
[TBL] [Abstract][Full Text] [Related]
44. Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry.
Grangemard I; Bonmatin JM; Bernillon J; Das BC; Peypoux F
J Antibiot (Tokyo); 1999 Apr; 52(4):363-73. PubMed ID: 10395272
[TBL] [Abstract][Full Text] [Related]
45. Activation of subtilin precursors by Bacillus subtilis extracellular serine proteases subtilisin (AprE), WprA, and Vpr.
Corvey C; Stein T; Düsterhus S; Karas M; Entian KD
Biochem Biophys Res Commun; 2003 Apr; 304(1):48-54. PubMed ID: 12705882
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of the chemical and antimicrobial properties of subtilin by site-directed mutagenesis.
Liu W; Hansen JN
J Biol Chem; 1992 Dec; 267(35):25078-85. PubMed ID: 1460009
[TBL] [Abstract][Full Text] [Related]
47. Use of alkaline phosphatase as a reporter polypeptide to study the role of the subtilin leader segment and the SpaT transporter in the posttranslational modifications and secretion of subtilin in Bacillus subtilis 168.
Izaguirre G; Hansen JN
Appl Environ Microbiol; 1997 Oct; 63(10):3965-71. PubMed ID: 9327561
[TBL] [Abstract][Full Text] [Related]
48. Nisin as a model food preservative.
Hansen JN
Crit Rev Food Sci Nutr; 1994; 34(1):69-93. PubMed ID: 8142045
[TBL] [Abstract][Full Text] [Related]
49. A 1H-NMR study of the solution conformation of cyclo(GRGDSPA): conformational effects on the physiological activity.
Mizutani R; Shimada I; Ueno Y; Yoda M; Kumagai H; Arata Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):966-73. PubMed ID: 1734894
[TBL] [Abstract][Full Text] [Related]
50. Solution structure of mu-conotoxin GIIIA analysed by 2D-NMR and distance geometry calculations.
Ott KH; Becker S; Gordon RD; Rüterjans H
FEBS Lett; 1991 Jan; 278(2):160-6. PubMed ID: 1991506
[TBL] [Abstract][Full Text] [Related]
51. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate.
Van Den Hooven HW; Doeland CC; Van De Kamp M; Konings RN; Hilbers CW; Van De Ven FJ
Eur J Biochem; 1996 Jan; 235(1-2):382-93. PubMed ID: 8631358
[TBL] [Abstract][Full Text] [Related]
52. Solution structure of microcin J25, the single macrocyclic antimicrobial peptide from Escherichia coli.
Blond A; Cheminant M; Ségalas-Milazzo I; Péduzzi J; Barthélémy M; Goulard C; Salomón R; Moreno F; Farías R; Rebuffat S
Eur J Biochem; 2001 Apr; 268(7):2124-33. PubMed ID: 11277936
[TBL] [Abstract][Full Text] [Related]
53. Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics.
Prasch T; Naumann T; Markert RL; Sattler M; Schubert W; Schaal S; Bauch M; Kogler H; Griesinger C
Eur J Biochem; 1997 Mar; 244(2):501-12. PubMed ID: 9119018
[TBL] [Abstract][Full Text] [Related]
54. The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.
Zimmermann N; Jung G
Eur J Biochem; 1997 Jun; 246(3):809-19. PubMed ID: 9219543
[TBL] [Abstract][Full Text] [Related]
55. Conformational study of bacterial lipopeptides: refinement of the structure of iturin A in solution by two-dimensional 1H-NMR and energy calculations.
Marion D; Genest M; Caille A; Peypoux F; Michel G; Ptak M
Biopolymers; 1986 Jan; 25(1):153-70. PubMed ID: 3081056
[No Abstract] [Full Text] [Related]
56. Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1.
Hosoda K; Ohya M; Kohno T; Maeda T; Endo S; Wakamatsu K
J Biochem; 1996 Feb; 119(2):226-30. PubMed ID: 8882709
[TBL] [Abstract][Full Text] [Related]
57. Solution structures of nisin A and its two major degradation products determined by n.m.r.
Lian LY; Chan WC; Morley SD; Roberts GC; Bycroft BW; Jackson D
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):413-20. PubMed ID: 1575686
[TBL] [Abstract][Full Text] [Related]
58. Surface location and orientation of the lantibiotic nisin bound to membrane-mimicking micelles of dodecylphosphocholine and of sodium dodecylsulphate.
Van Den Hooven HW; Spronk CA; Van De Kamp M; Konings RN; Hilbers CW; Van De Van FJ
Eur J Biochem; 1996 Jan; 235(1-2):394-403. PubMed ID: 8631359
[TBL] [Abstract][Full Text] [Related]
59. Isolation and structure of an antimitotic cyclic peptide, ustiloxin F: chemical interrelation with a homologous peptide, ustiloxin B.
Koiso Y; Morisaki N; Yamashita Y; Mitsui Y; Shirai R; Hashimoto Y; Iwasaki S
J Antibiot (Tokyo); 1998 Apr; 51(4):418-22. PubMed ID: 9630863
[TBL] [Abstract][Full Text] [Related]
60. Comparative study on the conformation of phalloidin, viroisin, and related derivatives in aqueous solution.
Kobayashi N; Endo S; Kobayashi H; Faulstich H; Wieland T; Munekata E
Eur J Biochem; 1995 Sep; 232(3):726-36. PubMed ID: 7588710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
